All In Biotech

Drug Trial Radar · NCT01709149

Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)

A Phase IIb, Multi-National, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS) (BENEFIT-ALS)

Last checked: Nov 20, 2026Latest source record: Mar 31, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 711 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

711

Actual

Start

Oct 2012

Primary completion

Mar 2014

Study completion Mar 2014

Sponsor

Lead sponsor
CytokineticsIndustry
Sponsor type
Industry
First posted
Oct 18, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research study is to evaluate the safety and effectiveness of CK-2017357 when taken with or without riluzole (also called Rilutek®) in patients with Amyotrophic Lateral Sclerosis (ALS).

Conditions

  • Amyotrophic Lateral Sclerosis

Interventions

  • CK-2017357Drug

    CK-2017357 125 mg tablets twice daily

  • Placebo tabletsOther

    Tablets

  • RiluzoleDrug

    Tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Change From Baseline in ALS Functional Rating Scale-Revised (ALSFRS-R) Total Score to the Average of Values Obtained at the End of Weeks 8 and 12 of Double-blind TreatmentTime frame: Baseline, 8 weeks, 12 weeks

Locations

75 sites in 8 countries. Site status is shown where the registry gives one.

  • Barrow Neurology

    Phoenix, Arizona

  • University of California, San Diego

    La Jolla, California

  • UC Irvine ALS & Neuromuscular Center

    Orange, California

  • Coordinated Clinical Research

    San Diego, California

  • California Pacific Medical Center Forbes Norris MDA/ALS Research Center

    San Francisco, California

  • Hospital for Special Care

    New Britain, Connecticut

  • The George Washington University

    Washington D.C., District of Columbia

  • Mayo Clinic Florida Department of Neurology

    Jacksonville, Florida

  • Emory University, School of Medicine

    Atlanta, Georgia

  • Georgia Health Sciences University

    Augusta, Georgia

  • Indiana University Department of Neurology

    Indianapolis, Indiana

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa

  • University of Kansas

    Kansas City, Kansas

  • Johns Hopkins University

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • University of Massachusetts Medical School

    Worcester, Massachusetts

  • University of Michigan

    Ann Arbor, Michigan

  • Henry Ford Hospital

    Detroit, Michigan

  • St Mary's Healthcare

    Grand Rapids, Michigan

  • Hennepin County Medical Center - Berman Center for Research

    Minneapolis, Minnesota

  • Saint Louis University

    St Louis, Missouri

  • Washington University

    St Louis, Missouri

  • Neurology Associates

    Lincoln, Nebraska

  • Dartmouth Hitchcock Medical Center

    Lebanon, New Hampshire

  • Hospital for Special Surgery

    New York, New York

  • University of Rochester

    Rochester, New York

  • SUNY Upstate Medical University

    Syracuse, New York

  • Carolinas Medical Center Department of Neurology

    Charlotte, North Carolina

  • Duke University

    Durham, North Carolina

  • Wake Forest University, School of Medicine

    Winston-Salem, North Carolina

  • Ohio State University Department of Neurology

    Columbus, Ohio

  • Providence ALS Center

    Portland, Oregon

  • Oregon Health & Science University

    Portland, Oregon

  • Penn State Hershey Neuroscience Clinics

    Hershey, Pennsylvania

  • Drexel Neurology

    Philadelphia, Pennsylvania

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • University of Pittsburgh

    Pittsburgh, Pennsylvania

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • Texas Neurology

    Dallas, Texas

  • Baylor College of Medicine

    Houston, Texas

Showing 40 of 75 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.